NCT00951496 2026-06-02Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerNational Cancer Institute (NCI)Phase 3 Completed1,560 enrolled 19 charts